• Sulfo-Cy3 NHS Ester: Hydrophilic Fluorescent Dye for Protein

  2026-07-23

  Sulfo-Cy3 NHS Ester is a hydrophilic fluorescent dye that enables efficient, high-fidelity labeling of proteins and peptides—even those with low solubility—by targeting amino groups. Its high water solubility, minimized quenching, and robust NHS ester chemistry make it ideal for advanced bioconjugation and cell biology assays. APExBIO’s A8107 kit is widely adopted in translational vascular biology and protein imaging workflows.

• Oleanolic Acid: iNOS Induction & Dual-Loaded Liposome Effici

  2026-07-23

  Oleanolic acid is a natural triterpenoid with demonstrated inducible nitric oxide synthase (iNOS) induction and cyclooxygenase-2 modulation, making it valuable for antiviral and immune pathway research. Its physicochemical properties support advanced dual-loaded liposome formulations, and validated nPEC methods enable accurate encapsulation efficiency measurement for precise workflow integration.

• Pexidartinib (PLX3397): Unraveling CSF1R Inhibition Beyond T

  2026-07-22

  Explore the multifaceted impact of Pexidartinib (PLX3397) on CSF1R-mediated signaling, advancing cancer research and neuroinflammation studies. This article offers a unique, evidence-driven perspective connecting microglial modulation to translational assay design.

• CHI3L1-IN-5 (Compound Z17): Redefining NF-κB Pathway Inhibit

  2026-07-22

  This article explores the mechanistic depth and translational value of CHI3L1-IN-5 (Compound Z17) as a highly specific CHI3L1-mediated NF-κB pathway inhibitor. Integrating recent evidence, it guides researchers on leveraging Z17’s dual action for robust modeling of neuroinflammation and astrocyte repair in Alzheimer’s disease, and positions the compound within a competitive and evolving landscape.

• Phosbind Acrylamide: Elevating Protein Phosphorylation Analy

  2026-07-21

  Phos binding reagent (Phosbind) acrylamide empowers researchers to detect phosphorylation-dependent mobility shifts in proteins without relying on phospho-specific antibodies. This workflow-ready phosphate-binding reagent delivers high-resolution, antibody-free SDS-PAGE phosphorylation analysis, unlocking new possibilities for dissecting dynamic post-translational modifications in both cancer and signaling studies.

• Applied Workflows for YM-155 Hydrochloride: Survivin Inhibit

  2026-07-21

  YM-155 hydrochloride delivers unprecedented selectivity as a survivin inhibitor, enabling precise apoptosis research and robust tumor regression modeling. This article demystifies its protocol setup, workflow optimization, and troubleshooting, drawing directly from pioneering in vitro methodologies and advanced xenograft studies.

• E. coli Uracil-DNA Glycosylase (UDG): Technical Use & Protoc

  2026-07-20

  E. coli Uracil-DNA Glycosylase (UDG) is applied to remove uracil residues from DNA, helping researchers prevent uracil-associated errors and PCR product contamination. It is not suitable for RNA substrates, short oligonucleotides, or diagnostic use, and is intended exclusively for research workflows demanding high-fidelity DNA amplification.

• AP-2α Downregulation of MGMT Sensitizes GBM to Temozolomide

  2026-07-20

  The referenced study uncovers that AP-2α directly suppresses MGMT expression, reducing temozolomide resistance in recurrent glioblastoma by enhancing DNA damage. This mechanistic insight highlights the AP-2α/MGMT axis as a promising therapeutic target for overcoming chemoresistance in GBM.

• Clarithromycin as a CYP3A Inhibitor: A Strategic Lever for T

  2026-07-19

  This thought-leadership article explores Clarithromycin’s mechanistic role as a CYP3A inhibitor in translational research, emphasizing its impact on drug-drug interaction studies, statin metabolism, and cardiovascular pharmacology. Integrating recent clinical and translational evidence, we guide researchers in experimental design and strategic decision-making, positioning APExBIO’s Clarithromycin as a gold-standard tool for reliable, reproducible workflows.

• α-Linolenic Acid (SKU C3934): Reliable Solutions for Cell As

  2026-07-18

  This article addresses common laboratory challenges in cell viability, proliferation, and cytotoxicity assays, demonstrating how α-Linolenic Acid (SKU C3934) offers reliable, reproducible solutions. Drawing on mechanistic insights, validated protocols, and comparative vendor analysis, researchers will gain practical guidance for integrating ALA into advanced lipid metabolism, cardiovascular, and immunology workflows.

• Ceruletide in Pancreatic Function Research: Protocols & Inno

  2026-07-17

  Ceruletide (caerulein) delivers unmatched reproducibility for modeling pancreatic fibrosis and gastrointestinal physiology. Explore advanced workflows, troubleshooting insights, and the integration of cutting-edge MFGE8-axis science to elevate your digestive disorder research.

• Targeting Adipose Tissue Macrophages with ATS-9R/siCcl2 in G

  2026-07-17

  This study introduces a targeted non-viral gene delivery approach using ATS-9R/siCcl2 complexes to selectively silence Ccl2 in adipose tissue macrophages, reducing inflammation and insulin resistance in gestational diabetes mellitus (GDM). The findings provide mechanistic insights and translational promise for precision gene silencing in metabolic disease research.

• SIRT1-Regulated Ran Lactylation Drives Astrocyte Polarizatio

  2026-07-16

  This study reveals that lactate accumulation after spinal cord injury promotes astrocyte polarization through SIRT1-dependent lactylation of the Ran GTPase at lysine 123, enhancing STAT3 nuclear transport. These findings clarify a mechanistic link between metabolic signaling, epigenetic regulation, and neuroregenerative responses, offering new research directions for CNS injury models.

• Angiotensin 1/2 (5-7): Applied Workflows for RAS & Viral Res

  2026-07-16

  Angiotensin 1/2 (5-7) is a uniquely versatile peptide for probing blood pressure regulation and spike protein interactions in bench workflows. This guide details optimized protocols, troubleshooting advice, and cutting-edge applications that leverage APExBIO's analytically pure formulation.

• Cyclophosphamide: Strategic Insights for Translational Oncol

  2026-07-15

  This thought-leadership article explores Cyclophosphamide’s mechanistic foundations as an alkylating chemotherapeutic agent, its role in apoptosis induction, and its transformative impact on translational cancer research. Through evidence-backed protocols, competitive context, and forward-looking guidance, the article provides actionable strategies for maximizing reproducibility and data quality in experimental and preclinical workflows. It further distinguishes itself by connecting protocol optimization with emerging translational opportunities, referencing both foundational literature and recent workflow innovations.

446 records 10/30 page Previous Next First page 上5页 678910 下5页 Last page